SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-12-190296
Filing Date
2012-04-27
Accepted
2012-04-27 14:12:59
Documents
3
Period of Report
2012-06-27
Effectiveness Date
2012-04-27

Document Format Files

Seq Description Document Type Size
1 NOTICE AND PROXY STATEMENT d330462ddef14a.htm DEF 14A 488645
2 GRAPHIC g330462g08f79.jpg GRAPHIC 16499
3 GRAPHIC g330462g33i24.jpg GRAPHIC 6977
  Complete submission text file 0001193125-12-190296.txt   522451
Mailing Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421
Business Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Filer) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23155 | Film No.: 12787724
SIC: 2836 Biological Products, (No Diagnostic Substances)